These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37371793)

  • 61. A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation.
    Mashima R; Ohira M; Okuyama T; Onodera M; Takada S
    Sci Rep; 2023 May; 13(1):7865. PubMed ID: 37188686
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
    Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
    J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene.
    Tomanin R; Karageorgos L; Zanetti A; Al-Sayed M; Bailey M; Miller N; Sakuraba H; Hopwood JJ
    Hum Mutat; 2018 Dec; 39(12):1788-1802. PubMed ID: 30118150
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiology and Genetics of Mucopolysaccharidosis Type VI in Russia.
    Voskoboeva E; Semyachkina A; Miklyaev O; Gamzatova A; Mikhaylova S; Vashakmadze N; Baydakova G; Omzar O; Pichkur N; Zakharova E; Kutsev S
    Front Mol Biosci; 2021; 8():780184. PubMed ID: 35118118
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity.
    Jin WD; Jackson CE; Desnick RJ; Schuchman EH
    Am J Hum Genet; 1992 Apr; 50(4):795-800. PubMed ID: 1550123
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).
    Saccone P; Cotugno G; Russo F; Mastrogiacomo R; Tessitore A; Auricchio A; De Leonibus E
    Sci Rep; 2014 Jan; 4():3644. PubMed ID: 24407717
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.
    Evers M; Saftig P; Schmidt P; Hafner A; McLoghlin DB; Schmahl W; Hess B; von Figura K; Peters C
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8214-9. PubMed ID: 8710849
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
    Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
    Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Changes in glycogen and glycosaminoglycan levels in hepatocytes of iduronate-2-sulfatase knockout mice before and after recombinant iduronate-2-sulfatase supplementation.
    Lee JH; Choe YH; Kim SJ; Paik KH; Jin DK
    Yonsei Med J; 2011 Mar; 52(2):263-7. PubMed ID: 21319344
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity.
    Archer LD; Langford-Smith KJ; Bigger BW; Fildes JE
    J Inherit Metab Dis; 2014 Jan; 37(1):1-12. PubMed ID: 23653226
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses.
    Monaco A; Fraldi A
    Autophagy; 2021 Nov; 17(11):3875-3876. PubMed ID: 34407725
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses.
    Tomatsu S; Gutierrez MA; Ishimaru T; Peña OM; Montaño AM; Maeda H; Velez-Castrillon S; Nishioka T; Fachel AA; Cooper A; Thornley M; Wraith E; Barrera LA; Laybauer LS; Giugliani R; Schwartz IV; Frenking GS; Beck M; Kircher SG; Paschke E; Yamaguchi S; Ullrich K; Isogai K; Suzuki Y; Orii T; Noguchi A
    J Inherit Metab Dis; 2005; 28(5):743-57. PubMed ID: 16151906
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.
    Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N
    PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets.
    Leal AF; Benincore-Flórez E; Rintz E; Herreño-Pachón AM; Celik B; Ago Y; Alméciga-Díaz CJ; Tomatsu S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613919
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteins.
    Xu T; Heon-Roberts R; Moore T; Dubot P; Pan X; Guo T; Cairo CW; Holley R; Bigger B; Durcan TM; Levade T; Ausseil J; Amilhon B; Gorelik A; Nagar B; Sturiale L; Palmigiano A; Röckle I; Thiesler H; Hildebrandt H; Garozzo D; Pshezhetsky AV
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712143
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.
    Burrow TA; Leslie ND
    Biologics; 2008 Jun; 2(2):311-20. PubMed ID: 19707363
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Generation of a novel disease model mouse for mucopolysaccharidosis type VI via c. 252T>C human
    Hosoba K
    Biochem Biophys Rep; 2022 Sep; 31():101321. PubMed ID: 36032399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.